646 results on '"Stetler-Stevenson, William"'
Search Results
2. Tissue inhibitors of metalloproteinases are proteolytic targets of matrix metalloproteinase 9
3. The Continuing Saga of Tissue Inhibitor of Metalloproteinase 2: Emerging Roles in Tissue Homeostasis and Cancer Progression
4. Whole organism profiling of the Timp gene family
5. Inhibition of Hepatic Stellate Cell Activation Suppresses Tumorigenicity of Hepatocellular Carcinoma in Mice
6. The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect
7. Mapping Extracellular Protein–Protein Interactions Using Extracellular Proximity Labeling (ePL).
8. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Matrix Proteolysis
9. Extracellular Phosphorylation of TIMP-2 by Secreted c-Src Tyrosine Kinase Controls MMP-2 Activity
10. The TIMP protein family: diverse roles in pathophysiology.
11. Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5
12. Tissue Inhibitors of Metalloproteinases
13. Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors
14. Abstract 2354: Regulation of TIMPs through MMP dependent cleavage in breast cancer
15. Abstract 2348: Mapping the interactome of matrisome targets using extracellular proximity labeling (ePL)
16. Abstract 4695: Expansion of the extracellular proximity labeling (ePL) technique to novel matrisome targets
17. Supplementary Tables 1-4, Figure Legends 1-2 from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
18. Data from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
19. Supplementary Figure 1 from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
20. Supplementary Figure 2 from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
21. c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells
22. Directed In Vivo Angiogenesis Assay (DIVAA) for the Screening of Angiogenesis Modulators
23. Human cardiac fibroblast extracellular matrix remodeling: dual effects of tissue inhibitor of metalloproteinase-2
24. Protocol to study secretome interactions using extracellular proximity labeling
25. Functional Interactions Between MMPs and TGF-β in Normal and Tumor Tissue
26. Matrix Metalloproteinases and Their Endogenous Inhibitors
27. Asymmetric Hsp90 N Domain SUMOylation Recruits Aha1 and ATP-Competitive Inhibitors
28. Matrix Metalloproteinases in Tumor Progression
29. Inhibitors of Matrix Metalloproteinases
30. Tissue Inhibitors of Metalloproteinases
31. Antagonism of VEGF-A–induced increase in vascular permeability by an integrin α3β1-Shp-1-cAMP/PKA pathway
32. Matrix Metalloproteinases: Changing Roles in Tumor Progression and Metastasis
33. Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coli
34. Abstract 3836: Mapping the interactome of the endogenous metalloproteinase inhibitor TIMP2 using extracellular proximity labeling (ePL)
35. Abstract 3837: The physiological relevance of TIMP dimer formation
36. Abstract 3843: TIMP1 and TIMP2 re-educate TGFβ induced pro-inflammatory/pro angiogenic decidual-like NK cells phenotype
37. Zymography, Casein Zymography, and Reverse Zymography: Activity Assays for Proteases and their Inhibitors
38. Matrix Metalloproteinase Inhibitors
39. An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo
40. Endogenous Angiogenesis Inhibitor Blocks Tumor Growth via Direct and Indirect Effects on Tumor Microenvironment
41. Regulation of Matrix Metalloproteinases during Extracellular Matrix Turnover
42. Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancer
43. Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model
44. Role of type IV collagenases in human breast cancer
45. TIMP-2 modulates VEGFR-2 phosphorylation and enhances phosphodiesterase activity in endothelial cells
46. Swe1 Wee1-Dependent Tyrosine Phosphorylation of Hsp90 Regulates Distinct Facets of Chaperone Function
47. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
48. MP39-02 OVEREXPRESSION OF MPS1 IN CLEAR CELL RENAL CELL CARCINOMA (CCRCC) CONFERS TUMOR SELECTIVITY ON HEAT SHOCK PROTEIN-90 (HSP90) INHIBITORS
49. Role of the α v β 3 Integrin in Human Melanoma Cell Invasion
50. Tissue Inhibitors of Metalloproteinases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.